Quick Answer
Health Catalyst, Inc. reported Diluted EPS of $2.55 per share (loss) for fiscal year 2025.
Health Catalyst, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$2.55 | -121.7% |
| 2024 | -$1.15 | +45.0% |
| 2023 | -$2.09 | +20.5% |
| 2022 | -$2.63 | +18.6% |
| 2021 | -$3.23 | -11.0% |
| 2020 | -$2.91 | +77.4% |
| 2019 | -$12.86 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.32 | -33.3% | +45.8% |
| June 30, 2025 | -$0.59 | -156.5% | -68.6% |
| March 31, 2025 | -$0.35 | +0.0% | -45.8% |
| September 30, 2024 | -$0.24 | +38.5% | -4.3% |
| June 30, 2024 | -$0.23 | +60.3% | +34.3% |
| March 31, 2024 | -$0.35 | +41.7% | +10.3% |
| September 30, 2023 | -$0.39 | +53.6% | +32.8% |
| June 30, 2023 | -$0.58 | +6.5% | +3.3% |
- Health Catalyst, Inc. showed a decrease of -121.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Health Catalyst, Inc.’s diluted eps has grown by 80.2% (from $12.86 per share (loss) to $2.55 per share (loss)).
- The most recent figure is from Health Catalyst, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: